Nortech Systems, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6565531042
USD
9.00
-0.4 (-4.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.05 k

Shareholding (Sep 2025)

FII

0.12%

Held by 2 FIIs

DII

98.34%

Held by 2 DIIs

Promoter

0.00%

How big is Nortech Systems, Inc.?

22-Jun-2025

As of Jun 18, Nortech Systems, Inc. has a market capitalization of 23.91 million, with net sales of 120.81 million and a net profit of -3.38 million over the last four quarters. The company reported shareholder's funds of 34.01 million and total assets of 72.44 million as of Dec 24.

Market Cap: As of Jun 18, Nortech Systems, Inc. has a market capitalization of 23.91 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Nortech Systems, Inc. reported net sales of 120.81 million and a net profit of -3.38 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 34.01 million and total assets of 72.44 million.

View full answer

What does Nortech Systems, Inc. do?

22-Jun-2025

Nortech Systems, Inc. is a micro-cap electronic manufacturing services company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $27 million and a net profit of -$1 million. The company has a market cap of $23.91 million and key metrics include a debt equity ratio of 0.39 and a return on equity of -7.77%.

Overview: <BR>Nortech Systems, Inc. is an electronic manufacturing services (EMS) company operating in the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap firm.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 27 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -1 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 23.91 Million (Micro Cap)<BR><BR>Key Metrics: <BR>Debt Equity: 0.39 <BR>Return on Equity: -7.77% <BR>Price to Book: 0.73<BR><BR>Contact Details: <BR>Address: 7550 Meridian Cir N Ste 150, MAPLE GROVE MN: 55369-4932 <BR>Tel: 1 952 3452244 <BR>Fax: 1 952 4490442 <BR>Website: http://www.nortechsys.com

View full answer

Should I buy, sell or hold Nortech Systems, Inc.?

22-Jun-2025

Who are in the management team of Nortech Systems, Inc.?

22-Jun-2025

As of March 2022, the management team of Nortech Systems, Inc. includes David Kunin (Chairman), Jay Miller (President and CEO), Kathleen Iverson, Danny Sachs, Philip Smith (all Directors), and independent Directors Kenneth Larson and Richard Perkins. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Nortech Systems, Inc. includes the following individuals:<BR><BR>- David Kunin, Chairman of the Board<BR>- Mr. Jay Miller, President, Chief Executive Officer, and Director<BR>- Ms. Kathleen Iverson, Director<BR>- Dr. Danny Sachs, Director<BR>- Mr. Philip Smith, Director<BR>- Kenneth Larson, Independent Director<BR>- Mr. Richard Perkins, Independent Director<BR><BR>This team is responsible for guiding the company's strategic direction and operations.

View full answer

Is Nortech Systems, Inc. overvalued or undervalued?

20-Sep-2025

As of March 31, 2025, Nortech Systems, Inc. is considered risky due to overvaluation indicated by negative valuation ratios and poor stock performance, with a year-to-date return of -8.36% compared to the S&P 500's 12.22%.

As of 31 March 2025, the valuation grade for Nortech Systems, Inc. has moved from fair to risky, indicating a significant deterioration in its financial health. The company appears to be overvalued, particularly given its negative valuation ratios, including a Price to Book Value of 0.75, an EV to EBITDA of -37.33, and an EV to Sales of 0.31. <BR><BR>In comparison to its peers, Nortech Systems' EV to EBITDA ratio of -37.33 is worse than LENSAR, Inc. at -12.34 and Singular Genomics Systems, Inc. at 0.55, both of which also carry a risky valuation. Additionally, the company's recent stock performance has lagged behind the S&P 500, with a year-to-date return of -8.36% compared to the index's 12.22%, further reinforcing the notion of overvaluation.

View full answer

Is Nortech Systems, Inc. technically bullish or bearish?

20-Sep-2025

As of August 28, 2025, Nortech Systems, Inc. shows a mildly bearish trend overall, with mixed technical indicators and significant underperformance compared to the S&P 500, reflecting a bearish sentiment despite some short-term bullish signals.

As of 28 August 2025, the technical trend for Nortech Systems, Inc. has changed from sideways to mildly bearish. The weekly MACD and KST indicators are mildly bullish, but the monthly MACD and KST are bearish, indicating mixed signals across different time frames. The daily moving averages are mildly bearish, and the Bollinger Bands show a mildly bullish stance on the weekly but mildly bearish on the monthly. Overall, the Dow Theory supports a mildly bullish view on both weekly and monthly time frames. <BR><BR>In terms of performance, Nortech has underperformed the S&P 500 across multiple periods, with a year-to-date return of -8.36% compared to the S&P's 12.22%, and a one-year return of -20.29% versus 17.14% for the index. This suggests a bearish sentiment despite some bullish indicators in the shorter term.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor Management Efficiency with a low ROCE of 8.91%

  • The company has been able to generate a Return on Capital Employed (avg) of 8.91% signifying low profitability per unit of total capital (equity and debt)
2

Poor long term growth as Net Sales has grown by an annual rate of 0.49% over the last 5 years

 
3

The company has declared Negative results for the last 4 consecutive quarters

4

Risky - Negative EBITDA

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 23 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.37

stock-summary
Return on Equity

-6.17%

stock-summary
Price to Book

0.70

Revenue and Profits:
Net Sales:
30 Million
(Quarterly Results - Sep 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.01%
0%
-7.01%
6 Months
11.66%
0%
11.66%
1 Year
-10.18%
0%
-10.18%
2 Years
-15.62%
0%
-15.62%
3 Years
-40.0%
0%
-40.0%
4 Years
-11.76%
0%
-11.76%
5 Years
11.25%
0%
11.25%

Nortech Systems, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0.49%
EBIT Growth (5y)
-198.33%
EBIT to Interest (avg)
1.88
Debt to EBITDA (avg)
0.74
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
3.04
Tax Ratio
10.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.00%
ROCE (avg)
8.91%
ROE (avg)
7.90%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.75
EV to EBIT
-17.56
EV to EBITDA
-37.33
EV to Capital Employed
0.82
EV to Sales
0.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.67%
ROE (Latest)
-7.77%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (1.54%)

Foreign Institutions

Held by 2 Foreign Institutions (0.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -2.87% vs -5.99% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 85.71% vs -158.33% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.50",
          "val2": "31.40",
          "chgp": "-2.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.30",
          "val2": "0.10",
          "chgp": "1,200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "-0.70",
          "chgp": "85.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.00%",
          "val2": "-9.30%",
          "chgp": "4.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -8.04% vs 3.88% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -118.84% vs 245.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "128.10",
          "val2": "139.30",
          "chgp": "-8.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.10",
          "val2": "8.00",
          "chgp": "-73.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.50",
          "chgp": "40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.30",
          "val2": "6.90",
          "chgp": "-118.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.90%",
          "val2": "42.70%",
          "chgp": "-3.98%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
30.50
31.40
-2.87%
Operating Profit (PBDIT) excl Other Income
1.30
0.10
1,200.00%
Interest
0.30
0.20
50.00%
Exceptional Items
0.00
-0.20
100.00%
Consolidate Net Profit
-0.10
-0.70
85.71%
Operating Profit Margin (Excl OI)
31.00%
-9.30%
4.03%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -2.87% vs -5.99% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 85.71% vs -158.33% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
128.10
139.30
-8.04%
Operating Profit (PBDIT) excl Other Income
2.10
8.00
-73.75%
Interest
0.70
0.50
40.00%
Exceptional Items
-0.60
0.00
Consolidate Net Profit
-1.30
6.90
-118.84%
Operating Profit Margin (Excl OI)
2.90%
42.70%
-3.98%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -8.04% vs 3.88% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -118.84% vs 245.00% in Dec 2023

stock-summaryCompany CV
About Nortech Systems, Inc. stock-summary
stock-summary
Nortech Systems, Inc.
Pharmaceuticals & Biotechnology
Nortech Systems Incorporated is an electronic manufacturing services (EMS) company. The Company offers a range of value-added engineering, technical and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management and post-market services. The Company's segment is Contract Manufacturing. The Company's manufacturing and engineering services include medical devices, printed circuit board assemblies, wire and cable assemblies, and electromechanical assemblies. The Company's manufacturing facilities are located at Bemidji, Blue Earth, Merrifield, Eden Prairie, Milaca and Mankato in Minnesota; Augusta in Wisconsin; Monterrey in Mexico, and Suzhou in China. The Company serves approximately three markets within the EMS industry, such as Aerospace and Defense, Medical/Life Sciences and the Industrial market, which includes industrial equipment, transportation, vision, agriculture, oil and gas.
Company Coordinates stock-summary
Company Details
7550 Meridian Cir N Ste 150 , MAPLE GROVE MN : 55369-4932
stock-summary
Tel: 1 952 3452244
stock-summary
Registrar Details